LENZ THERAPEUTICS INC (LENZ) Stock Income Statement
NASDAQ:LENZ - US52635N1037 - Common Stock
38.2 USD
+0.83 (+2.22%)
37.98 USD
-0.22 (-0.58%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.00M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 66.96M | 58.61M | 73.11M | 105.64M | 60.44M | |||
| Research and Development | 27.20M | 29.80M | 32.14M | 72.79M | 37.93M | |||
| Selling, General, and Administrative Expenses | 39.76M | 28.81M | 40.97M | 32.85M | 22.51M | |||
| Operating Income | -61.96M | -58.61M | -73.11M | -105.64M | -60.44M | |||
| Interest Income/Expense | 9.87M | 8.55M | 10.95M | N/A | 0.00 | |||
| Other Income/Expense | 190.00K | 289.00K | -338.00K | 4.59M | -10.32M | |||
| Non Recurring Items | N/A | N/A | -62.08M | N/A | N/A | |||
| Income Before Taxes | -51.90M | -49.77M | -124.65M | -101.05M | -70.76M | |||
| Income Tax | N/A | 1.00K | N/A | N/A | N/A | |||
| Net Income | -52.40M | -49.77M | -124.65M | -101.05M | -70.76M | |||
| EBITDA | -61.87M | -58.55M | -70.70M | -103.29M | -59.71M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.90 | -2.34 | -15.30 | -1.84 | -2.45 | |||
| Non GAAP EPS | -1.88 | -4.77 | -12.75 | -1.85 | N/A | |||
| Statistics | ||||||||
| Profit Margin | -1047.96% | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | -1239.16% | N/A | N/A | N/A | N/A | |||
All data in USD